Dextech Net Receivables from 2010 to 2026
| LQ0 Stock | 1.00 0.02 1.96% |
Net Receivables | First Reported 2010-12-31 | Previous Quarter 425.7 K | Current Value 378.4 K | Quarterly Volatility 25 K |
Check Dextech Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Dextech Medical's main balance sheet or income statement drivers, such as Tax Provision of 0.0, Net Interest Income of 458.2 K or Interest Income of 458.2 K, as well as many indicators such as . Dextech financial statements analysis is a perfect complement when working with Dextech Medical Valuation or Volatility modules.
Dextech | Net Receivables |
Currently Active Assets on Macroaxis
Other Information on Investing in Dextech Stock
Dextech Medical financial ratios help investors to determine whether Dextech Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Dextech with respect to the benefits of owning Dextech Medical security.